Assertion: nitroglycerin's use | /r/HasProperty | contraindicated
Facets:
value: in patients
type: LOCATION
value: absolutely
type: DEGREE
value: in patients with severe anemia
type: OTHER
Source sentences:
text: Concomitant use of Nitroglycerin in 5% Dextrose Injection with phosphodiesterase inhibitors (e.g. sildenafil, tadalafil, or vardenafil) can cause hypotension and is contraindicated (see Contraindications).
text: Concomitant use of Nitroglycerin in 5% Dextrose Injection with riociguat, a soluble guanylate cyclase stimulator, can cause hypotension and is contraindicated (see Contraindications).
text: Concomitant use of Nitro-Dur with phosphodiesterase inhibitors in any form is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of Nitro-Dur with riociguat, a soluble guanylate cyclase stimulator, is contraindicated (see CONTRAINDICATIONS).
text: Some manufacturers and medical references consider the use of nitrates and nitrites to be contraindicated in patients with severe anemia.
text: The use of intravenous nitroglycerin is contraindicated in patients with constrictive pericarditis, pericardial tamponade, or restrictive cardiomyopathy.
text: Concomitant use of Minitran with phosphodiesterase inhibitors in any form is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of Minitran with riociguat, a soluble guanylate cyclase stimulator, is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of Nitroglycerin Transdermal infusion system with phosphodiesterase inhibitors in any form is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of Nitroglycerin Transdermal infusion system with riociguat, a soluble guanylate cyclase stimulator, is contraindicated (see CONTRAINDICATIONS).
text: Use of Transderm-Nitro (nitroglycerin) transdermal system is contraindicated in patients using Viagra® (sildenafil) because sildenafil may amplify the vasodilatory effects of Transderm-Nitro resulting in severe hypotension.
text: Concomitant use of Nitroglycerin in 5% Dextrose Injection with phosphodiesterase inhibitors (e.g., sildenafil, tadalafil, or vardenafil) can cause hypotension and is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of Nitroglycerin in 5% Dextrose Injection with riociguat, a soluble guanylate cyclase stimulator, can cause hypotension and is contraindicated (see CONTRAINDICATIONS).
text: Use of RECTIV within a few days of PDE5 inhibitors is contraindicated.
text: Concomitant use of Nitroglycerin Transdermal Systems with phosphodiesterase inhibitors in any form is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of Nitroglycerin Transdermal Systems with riociguat, a soluble guanylate cyclase stimulator, is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of Nitroglycerin Transdermal Systems with phosphodiesterase inhibitors in any form is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of Nitroglycerin Transdermal Systems with riociguat, a soluble guanylate cyclase stimulator, is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of nitroglycerin with soluble guanylate cyclasestimulators is contraindicated (see CONTRAINDICATIONS).
text: Concurrent use of nitroglycerin with PDE-5 inhibitors (e.g., sildenafil citrate, vardenafil hydroxide, tadalafil) is absolutely contraindicated.
text: Concomitant use of Nitroglycerin in 5% Dextrose Injection with phosphodiesterase inhibitors (e.g. sildenafil, tadalafil, or vardenafil) can cause hypotension and is contraindicated (see Contraindications).
text: Concomitant use of Nitroglycerin in 5% Dextrose Injection with riociguat, a soluble guanylate cyclase stimulator, can cause hypotension and is contraindicated (see Contraindications).
text: Concomitant use of nitroglycerin transdermal infusion system with phosphodiesterase inhibitors in any form is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of nitroglycerin transdermal infusion system with riociguat, a soluble guanylate cyclase stimulator, is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of Nitroglycerin Transdermal Systems with phosphodiesterase inhibitors in any form is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of Nitroglycerin Transdermal Systems with riociguat, a soluble guanylate cyclase stimulator, is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of Nitroglycerin Transdermal Infusion System with phosphodiesterase inhibitors in any form is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of Nitroglycerin Transdermal Infusion System with riociguat, a soluble guanylate cyclase stimulator, is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of nitroglycerin transdermal infusion system with phosphodiesterase inhibitors in any form is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of nitroglycerin transdermal infusion system with riociguat, a soluble guanylate cyclase stimulator, is contraindicated (see CONTRAINDICATIONS).
text: Use of Nitroglycerin Transdermal Systems is contraindicated in patients using Viagra® (sildenafil) because sildenafil may amplify the vasodilatory effects of Nitroglycerin Transdermal Systems resulting in severe hypotension.
text: Use of RECTIV within a few days of PDE5 inhibitors is contraindicated.
text: Concomitant use of MINITRAN with phosphodiesterase inhibitors in any form is contraindicated (see CONTRAINDICATIONS).
text: Concomitant use of MINITRAN with riociguat, a soluble guanylate cyclase stimulator, is contraindicated (see CONTRAINDICATIONS).
text: Use of nitroglycerin ointment within a few days of PDE5 inhibitors is contraindicated.
text: Concomitant use of MINITRAN with phosphodiesterase inhibitors in any form is contraindicated (see CONTRAINDICATIONS ).
text: Concomitant use of MINITRAN with riociguat, a soluble guanylate cyclase stimulator, is contraindicated (see CONTRAINDICATIONS ).